MedTrace Logo

Mast Cells Are Involved in the Mechanism of NPSLE Epilepsy

NCT05607368 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2022-11-07

No results posted yet for this study

Summary

Tryptase, TLR4, and anti-NR2A antibodies were measured in serum, cerebrospinal fluid, and subjects and other markers to assess their relevance to disease activity, aiming to find new therapeutic targets,Timely intervention to improve the prognosis of SLE and improve the quality of life of patients with SLE.

Conditions

  • Lupus Erythematosus, Systemic

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Principal Investigators

  • Qin Huang, Doctor · Southern Medical University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05607368 on ClinicalTrials.gov